[Results of treatment with recombinant human growth hormone in children with growth retardation in end-stage renal disease].

Abstract

The aim of the study was to estimate the results of recombinant human growth hormone (rhGH) treatment in children with end-stage renal disease (ESRD). 60 growth retarded children with ESRD (mean age 11.2 +/- 7.2 years) were treated with rhGH at a dose of 1-1.1 IU/kg/week. The time of observation was 24 months. Thirty children completed first year, 18… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.